These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19853188)

  • 21. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.
    Farnsworth A
    Acta Cytol; 2011; 55(4):307-12. PubMed ID: 21791898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer screening: from the Papanicolaou smear to the vaccine era.
    Crum CP; Abbott DW; Quade BJ
    J Clin Oncol; 2003 May; 21(10 Suppl):224s-230s. PubMed ID: 12743139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
    Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K; Tay SK
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):154-9. PubMed ID: 21585695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV testing for cervical cancer screening in Croatia.
    Grce M; Grahovac B; Rukavina T; Vrdoljak-Mozetic D; Glavas-Obrovac L; Kaliterna V; Zele-Starcević L
    Coll Antropol; 2007 Apr; 31 Suppl 2():67-71. PubMed ID: 17598507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R; Andrei C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands.
    Coupé VM; de Melker HE; Snijders PJ; Meijer CJ; Berkhof J
    Vaccine; 2009 Aug; 27(37):5111-9. PubMed ID: 19567242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Summary of the practice guideline 'Prevention and early diagnosis of cervical cancer' of the Dutch College of General Practitioners].
    Janssen PG; Boomsma LJ; Buis PA; Collette C; Boukes FS; Goudswaard AN
    Ned Tijdschr Geneeskd; 2009; 153():A517. PubMed ID: 20051149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervical cancer screening in Mediterranean countries: implications for the future.
    Syrjänen K; Di Bonito L; Gonçalves L; Murjal L; Santamaria M; Mahovlic V; Karakitsos P; Onal B; Schmitt FC
    Cytopathology; 2010 Dec; 21(6):359-67. PubMed ID: 20718841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introducing HPV triage into the English cervical cancer screening program: consequences for participation.
    Philips Z; Avis M; Whynes DK
    Women Health; 2006; 43(2):17-34. PubMed ID: 17000609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.
    Hestbech MS; Lynge E; Kragstrup J; Siersma V; Vazquez-Prada Baillet M; Brodersen J
    BMJ Open; 2015 Aug; 5(8):e007921. PubMed ID: 26275901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control.
    Mayrand MH; Franco EL
    Future Oncol; 2010 Nov; 6(11):1725-33. PubMed ID: 21142659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus infection (HPV) & screening strategies for cervical cancer.
    Sehgal A; Singh V
    Indian J Med Res; 2009 Sep; 130(3):234-40. PubMed ID: 19901432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 40. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
    Wheeler CM
    Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.